DKFZ-PSMA-617
: 2-[3-(1-Carboxy-5-{3-naphthalen-2-yl-2-[(4-{[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-methyl}-cyclohexanecarbonyl)-amino]-propionylamino}-pentyl)-ureido]-pentanedioic acid
: DKFZ-PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.
: DKFZ-PSMA-617 is an innovative and effective therapy for castrate-resistant metastatic prostate cancer patients.
Properties
: Colourless / white / off-white
Safety Information
Safety Information for this product is unavailable at this time.
| Packings | Price (INR) |
|
1 mg
|
POR
|
|
5 x 1 mg
|
POR
|
|
25 x 1 mg
|
POR
|